À propos de Rhythm Pharmaceuticals
- Secteur
- Biotechnology Research
- Taille de l’entreprise
- 201 à 500 employés
- Siège social
- Boston, MA
- Fondation
- 2008
- Type d’entreprise
- Société cotée en bourse
- Nom sur le profil de l’entreprise
- Rhythm Pharmaceuticals Inc.
Présentation originale de l’entreprise
Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on transforming the lives of patients with rare neuroendocrine diseases by rapidly advancing care and precision medicines that address the root cause.
The Company develops medicines for previously untreatable or undertreated diseases and provides meaningful support for healthcare providers and patients and their families. In addition to commercializing its lead asset in North America, Europe and other regions, Rhythm is advancing a broad clinical development program in rare MC4R pathway diseases, as well as investigational MC4R agonists, and a preclinical suite of small molecules for the treatment of congenital hyperinsulinism.
At Rhythm, we know our work makes an important difference in the lives of patients and their families around the world. Every employee contributes to the company’s goal of discovering new treatments for rare diseases that no other company is developing. As a fast-growing company with an exciting future, we offer a collaborative environment where employees’ contributions truly matter, which is one of the many reasons we were recognized as one of The Boston Globe’s Top Places to Work in Massachusetts for 2023 and 2024.
Spécialités
- genetics
- obesity
- peptides
- metabolism
- rare disease
- biotechnology
- Pharmaceuticals
- Research
- Health
- Medicine
- Clinical Trials
- Endocrinology
- Orphan disease
- Science
- Advocacy
- Epidemiology
- Orphan drugs
- and metabolic
Établissements
222 Berkeley Street, 12th Floor, Boston, MA 02116, US
Les emplacements du profil de l’entreprise peuvent être hors de cette zone. Ils ne recrutent pas tous.
Domaines d’activité
- Developer Platform
- Health Care
- Biotechnology
- Pharmaceutical
- Therapeutics
Sur LinkedIn
- Abonnés
- 60 203
- Personnes liées à cette entreprise
- 487
Personnes qui indiquent cette entreprise sur LinkedIn. Il ne s’agit pas d’un effectif vérifié. Les chiffres proviennent du profil enregistré.
Financement obtenu
1 220 500 000 USD
Total indiqué par Crunchbase, en dollars américains. Il s’agit du financement obtenu, et non du chiffre d’affaires ou de la valeur de l’entreprise.
Découvrir l’entreprise
Catégorie d’employeur
Autre employeur
Catégorie estimée à partir du profil de l’entreprise, sans confirmation de l’employeur.